Development and validation of a machine learning model for predicting invasive breast cancer using 26 routine clinical examination indicators - Scorecard - MDSpire

Development and validation of a machine learning model for predicting invasive breast cancer using 26 routine clinical examination indicators

  • By

  • Lijuan Pan

  • Wenjing Deng

  • Ziwei Zhao

  • Yulong Liu

  • Xuelian Peng

  • Chunyan Yang

  • Baoru Han

  • Shan Shi

  • Jin Li

  • May 10, 2026

  • 0 min

Share

Clinical Scorecard: Creation and assessment of a machine learning algorithm for forecasting invasive breast cancer utilizing 26 standard clinical evaluation metrics

At a Glance

CategoryDetail
ConditionInvasive Breast Cancer (IBC)
Key MechanismsMachine learning algorithms utilizing routine clinical examination indicators.
Target PopulationFemale patients diagnosed with invasive breast diseases.
Care SettingPrimary care centers and community hospitals.

Key Highlights

  • Approximately 2.26 million new cases of IBC diagnosed annually worldwide.
  • Traditional diagnostic methods have limitations including low accuracy and high costs.
  • Machine learning can enhance diagnostic efficiency and accuracy in resource-limited areas.
  • Study analyzed 1,175 female patients to develop predictive models for IBC.
  • 26 routine clinical examination indicators were identified for model development.

Guideline-Based Recommendations

Diagnosis

  • Utilize routine clinical examination indicators for early detection of IBC.

Management

  • Implement machine learning models to optimize treatment timelines for high-risk patients.

Monitoring & Follow-up

  • Regularly assess model performance using internal validation cohorts.

Risks

  • Consider risks associated with traditional diagnostic methods, including misdiagnosis.

Patient & Prescribing Data

Female patients with invasive breast diseases, specifically IBC.

Early identification of high-risk patients can lead to timely interventions.

Clinical Best Practices

  • Integrate machine learning techniques with routine clinical indicators for better diagnostic outcomes.
  • Focus on high-risk screening in under-resourced healthcare settings.

Related Resources & Content

Original Source(s)

Development and validation of a machine learning model for predicting invasive breast cancer using 26 routine clinical examination indicators

  • by Lijuan Pan, Wenjing Deng, Ziwei Zhao, Yulong Liu, Xuelian Peng, Chunyan Yang, Baoru Han, Shan Shi, Jin Li

  • May 10, 2026

Related Content

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms